Mark A Meltz

CIK 1771329 · General Counsel · last filed 2026-02-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

3

Total Filings

16

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LYEL	General Counsel	—	$13.50	—	$0	2	2026-02-11
Kinnate Biopharma Inc. (KNTE) Delisted	COO GENERAL COUNSEL SECRETARY	27,578	$2.65	$73.1K	$0	10	2024-03-05
BOLD	SVP, General Counsel	0	$1.41	$0	$0	3	2020-01-15

Recent Filings · Page 2 of 2

16 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-09-02	Kinnate Biopharma Inc. (KNTE) Delisted	Grant (A)	+25,000	$0	EDGAR
2022-02-15	Kinnate Biopharma Inc. (KNTE) Delisted	Grant (A)	—	$0	EDGAR
2021-02-16	Kinnate Biopharma Inc. (KNTE) Delisted	Grant (A)	—	$0	EDGAR
2020-01-15	BOLD	Mixed	−32,705	-$1.96M	EDGAR
2019-12-16	BOLD	Tax (F)	−4,628	-$274.8K	EDGAR
2019-04-01	BOLD	Grant (A)	+37,333	$0	EDGAR

Showing 11–16 of 16

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.